An appraisal on recent medicinal perspective of curcumin degradant: Dehydrozingerone (DZG).

[1]  L. Savegnago,et al.  Twice acting antioxidants: synthesis and antioxidant properties of selenium and sulfur-containing zingerone derivatives , 2015 .

[2]  G. Rimbach,et al.  Thermal stability, antioxidant, and anti-inflammatory activity of curcumin and its degradation product 4-vinyl guaiacol. , 2015, Food & function.

[3]  G. Abbas,et al.  Saponins: the phytochemical with an emerging potential for curing clinical depression , 2015, Natural product research.

[4]  J. O. Lee,et al.  Dehydrozingerone exerts beneficial metabolic effects in high-fat diet-induced obese mice viaAMPK activation in skeletal muscle , 2015, Journal of cellular and molecular medicine.

[5]  J. Snyder,et al.  Eliminating the Heart from the Curcumin Molecule: Monocarbonyl Curcumin Mimics (MACs) , 2014, Molecules.

[6]  L. Savegnago,et al.  Antidepressant-like activity of dehydrozingerone: Involvement of the serotonergic and noradrenergic systems , 2014, Pharmacology Biochemistry and Behavior.

[7]  R. Amarowicz,et al.  Protective effects of equimolar mixtures of monomer and dimer of dehydrozingerone with α-tocopherol and/or ascorbyl palmitate during bulk lipid autoxidation. , 2014, Food chemistry.

[8]  J. Fajemiroye,et al.  Anxiolytic and antidepressant like effects of natural food flavour (E)-methyl isoeugenol. , 2014, Food & function.

[9]  P. Zou,et al.  Synthesis and biological evaluation of allylated and prenylated mono-carbonyl analogs of curcumin as anti-inflammatory agents. , 2014, European journal of medicinal chemistry.

[10]  C. Teng,et al.  Synthesis of Analogues of Gingerol and Shogaol, the Active Pungent Principles from the Rhizomes of Zingiber officinale and Evaluation of Their Anti-Platelet Aggregation Effects , 2014, International journal of molecular sciences.

[11]  Zai-Qun Liu,et al.  Asymmetrical mono-carbonyl ferrocenylidene curcumin and their dihydropyrazole derivatives: Which possesses the highest activity to protect DNA or scavenge radical? , 2014, Medicinal Chemistry Research.

[12]  Jung-Chun Liao,et al.  Antidepressant-like activity of turmerone in behavioral despair tests in mice , 2013, BMC Complementary and Alternative Medicine.

[13]  Xiaokun Li,et al.  Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells , 2013, BMC Cancer.

[14]  H. Fu,et al.  Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma. , 2013, Organic & biomolecular chemistry.

[15]  K. Misra,et al.  Human papilloma virus 16 e6 protein as a target for curcuminoids, curcumin conjugates and congeners for chemoprevention of oral and cervical cancers , 2013, Interdisciplinary Sciences: Computational Life Sciences.

[16]  G. Liang,et al.  Discovery and evaluation of piperid-4-one-containing mono-carbonyl analogs of curcumin as anti-inflammatory agents. , 2013, Bioorganic & medicinal chemistry.

[17]  J. Ham,et al.  Cytotoxicity of Substituted Benzimidazolyl Curcumin Mimics Against Multi-Drug Resistance Cancer Cell , 2013 .

[18]  Chengguang Zhao,et al.  Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs). , 2013, Current pharmaceutical design.

[19]  D. Liao,et al.  Synthesis and Anticancer Activity of Mono-Carbonyl Analogues of Curcumin , 2013 .

[20]  L. Rao,et al.  In vitro antifungal activity of dehydrozingerone and its fungitoxic properties. , 2013, Journal of food science.

[21]  T. Sakai,et al.  Dehydrozingerone, a structural analogue of curcumin, induces cell-cycle arrest at the G2/M phase and accumulates intracellular ROS in HT-29 human colon cancer cells. , 2012, Journal of natural products.

[22]  Liang Shen,et al.  Low stability remedies the low bioavailability of curcumin , 2012 .

[23]  Liang Shen,et al.  The pharmacology of curcumin: is it the degradation products? , 2012, Trends in molecular medicine.

[24]  J. Ham,et al.  Synthesis of substituted benzimidazolyl curcumin mimics and their anticancer activity. , 2012, Bioorganic & medicinal chemistry letters.

[25]  L. Rao,et al.  Structure-function activity of dehydrozingerone and its derivatives as antioxidant and antimicrobial compounds , 2014, Journal of Food Science and Technology.

[26]  M. S. Brewer.  NATURAL ANTIOXIDANTS: SOURCES, COMPOUNDS, MECHANISMS OF ACTION, AND POTENTIAL APPLICATIONS , 2011 .

[27]  P. Paul,et al.  Effect of Dehydrozingerone, a half analog of curcumin on dexamethasone-delayed wound healing in albino rats , 2011, Molecular and Cellular Biochemistry.

[28]  Zai-Qun Liu,et al.  Ferrocenyl-substituted curcumin: can it influence antioxidant ability to protect DNA? , 2011, European journal of medicinal chemistry.

[29]  Zai-Qun Liu,et al.  Feruloylacetone as the model compound of half-curcumin: synthesis and antioxidant properties. , 2011, European journal of medicinal chemistry.

[30]  J. Gut,et al.  Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds. , 2010, Bioorganic & medicinal chemistry.

[31]  D. Linseman,et al.  Nutraceutical Antioxidants as Novel Neuroprotective Agents , 2010, Molecules.

[32]  H. Tokuda,et al.  Cancer preventive agents 10. Prenylated dehydrozingerone analogs as potent chemopreventive agents , 2010, Journal of Asian natural products research.

[33]  Liang Shen,et al.  Insights into the inhibition of xanthine oxidase by curcumin. , 2009, Bioorganic & medicinal chemistry letters.

[34]  Jian Xiao,et al.  Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents. , 2009, Bioorganic & medicinal chemistry.

[35]  D. Suresh,et al.  Degradation of bioactive spice compound: curcumin during domestic cooking , 2009 .

[36]  S. Kulkarni,et al.  Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes , 2009, Pharmacology Biochemistry and Behavior.

[37]  J. Elguero,et al.  Synthesis and biological evaluation of curcuminoid pyrazoles as new therapeutic agents in inflammatory bowel disease: effect on matrix metalloproteinases. , 2009, Bioorganic & medicinal chemistry.

[38]  B. Aggarwal,et al.  Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. , 2009, Trends in pharmacological sciences.

[39]  N. Sreejayan,et al.  Inhibitory Effect of Dehydrozingerone on Vascular Smooth Muscle Cell Function , 2007, Journal of cardiovascular pharmacology.

[40]  Robert A Newman,et al.  Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.

[41]  S. Manjula,et al.  Free radical scavenging and radioprotective activity of dehydrozingerone against whole body gamma irradiation in Swiss albino mice. , 2007, Chemico-biological interactions.

[42]  M. Hung,et al.  Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant--taxoid conjugates as novel cytotoxic agents. , 2007, Bioorganic & medicinal chemistry letters.

[43]  K. Lee,et al.  Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents. , 2007, Bioorganic & medicinal chemistry.

[44]  G. Litwinienko,et al.  DSC study of linolenic acid autoxidation inhibited by BHT, dehydrozingerone and olivetol , 2007 .

[45]  E. Barreiro,et al.  Molecular hybridization: a useful tool in the design of new drug prototypes. , 2007, Current medicinal chemistry.

[46]  M. Másson,et al.  Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. , 2007, International journal of pharmaceutics.

[47]  K. Lee,et al.  Dehydrozingerone, chalcone, and isoeugenol analogues as in vitro anticancer agents. , 2006, Journal of natural products.

[48]  Eun Kyoung Ryu,et al.  Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. , 2006, Journal of medicinal chemistry.

[49]  E. Bobrovnikova-Marjon,et al.  Activation of NFκB is inhibited by curcumin and related enones , 2006 .

[50]  G. Grogan.  Emergent mechanistic diversity of enzyme-catalysed β-diketone cleavage , 2005 .

[51]  C. Teng,et al.  Isolation of a Natural Antioxidant, Dehydrozingerone from Zingiber officinale and Synthesis of Its Analogues for Recognition of Effective Antioxidant and Antityrosinase Agents , 2005, Archives of pharmacal research.

[52]  T. Tanahashi,et al.  Quantitative structure-activity relationship analyses of antioxidant and free radical scavenging activities for hydroxybenzalacetones. , 2004, Bioorganic & medicinal chemistry letters.

[53]  Lisa St John-Williams,et al.  Enzymology of a carbonyl reduction clearance pathway for the HIV integrase inhibitor, S-1360: role of human liver cytosolic aldo-keto reductases. , 2004, Chemico-biological interactions.

[54]  Darrick S. H. L. Kim,et al.  Side-chain length is important for shogaols in protecting neuronal cells from beta-amyloid insult. , 2004, Bioorganic & medicinal chemistry letters.

[55]  Y. K. Kim,et al.  Chemical Hypoxia-Induced Cell Death in Human Glioma Cells: Role of Reactive Oxygen Species, ATP Depletion, Mitochondrial Damage and Ca2+ , 2003, Neurochemical Research.

[56]  M. Rao,et al.  Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates , 1994, Molecular and Cellular Biochemistry.

[57]  David J Newman,et al.  Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.

[58]  D. W. Ribbons,et al.  Acetylacetone-cleaving enzyme Dke1: a novel C-C-bond-cleaving enzyme from Acinetobacter johnsonii. , 2003, The Biochemical journal.

[59]  S. B. Rao,et al.  Novel Method Of Synthesis Of Curcuminoids And Derivative Of Ibuprofen As Potent Antiinflammatory Agent , 2002 .

[60]  B. Khambay,et al.  Insect growth inhibition, antifeedant and antifungal activity of compounds isolated/derived from Zingiber officinale Roscoe (ginger) rhizomes. , 2001, Pest management science.

[61]  M. Nair,et al.  Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[62]  Matthew S. Mitchell,et al.  Isolation of Curcumin from Turmeric , 2000 .

[63]  H. Nishino,et al.  Structure-activity relationship in potentially anti-tumor promoting benzalacetone derivatives, as assayed by the epstein-barr virus early antigen activation. , 2000, Mutation research.

[64]  D J Newman,et al.  The influence of natural products upon drug discovery. , 2000, Natural product reports.

[65]  S. Jovanovic,et al.  H-Atom Transfer Is A Preferred Antioxidant Mechanism of Curcumin , 1999 .

[66]  K. Priyadarsini,et al.  Properties of phenoxyl radical of dehydrozingerone, a probable antioxidant , 1999 .

[67]  M. Rao,et al.  In vitro and in vivo effects of phenolic antioxidants against cisplatin-induced nephrotoxicity. , 1999, Journal of biochemistry.

[68]  G. Samuelsson.  Drugs of natural origin : a textbook of pharmacognosy , 1999 .

[69]  H. Nishino,et al.  Inhibitory effects of dehydrozingerone and related compounds on 12-O-tetradecanoylphorbol-13-acetate induced Epstein-Barr virus early antigen activation. , 1998, Cancer letters.

[70]  R. Sangwan,et al.  Plant‐derived products as antimutagens , 1998 .

[71]  S. B. Rao,et al.  Synthesis And Pharmacological Activity Of Some Mannich Bases Of Dehydrozingerone , 1998 .

[72]  K. Priyadarsini,et al.  Physico-chemical properties and antioxidant activities of methoxy phenols. , 1998, Free radical biology & medicine.

[73]  Jen-kun Lin,et al.  Stability of curcumin in buffer solutions and characterization of its degradation products. , 1997, Journal of pharmaceutical and biomedical analysis.

[74]  H. Timmerman,et al.  1,5-Diphenyl-1,4-pentadiene-3-ones and cyclic analogues as antioxidative agents. Synthesis and structure-activity relationship , 1997 .

[75]  Y. Saito,et al.  Antimutagenic effects of dehydrozingerone and its analogs on UV-induced mutagenesis in Escherichia coli. , 1997, Mutation research.

[76]  D J Newman,et al.  Natural products in drug discovery and development. , 1997, Journal of natural products.

[77]  K. N. Rajasekharan,et al.  Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. , 1996, Mutation research.

[78]  G. Kuttan,et al.  Anti-tumour and free radical scavenging activity of synthetic curcuminoids , 1996 .

[79]  G. Kuttan,et al.  Anti-tumour and antioxidant activity of natural curcuminoids. , 1995, Cancer letters.

[80]  T. Devasagayam,et al.  Diminution of singlet oxygen-induced DNA damage by curcumin and related antioxidants. , 1994, Mutation research.

[81]  Bin-Nan Wu,et al.  A new β-adrenoceptor blocking agent derived from dehydrozingerone , 1994 .

[82]  M. Rao,et al.  Dehydrozingerone and isoeugenol as inhibitors of lipid peroxidation and as free radical scavengers. , 1993, Biochemical pharmacology.

[83]  G. Elias,et al.  Synthesis and anti-inflammatory activity of substituted (E)-4-phenyl-3-buten-2-ones , 1988 .

[84]  G. Vidari,et al.  Dehydrozingerone from Aframomum giganteum , 1976 .

[85]  Mi-Kyung Sung,et al.  The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease , 2022 .